Curr cancer drug targets impact factor
WebApr 6, 2024 · Drugs. Stay up to date with the latest developments in therapeutics by reading the world’s most respected source of authoritative drug information. For 50 years Drugs has been the definitive journal of drugs and therapeutics, promoting optimum pharmacotherapy by publishing reviews and original research authored by leading international ... WebThe latest impact factor of Current Drug Therapy and all the other SCI journals was released on 30th June 2024 by Clarivate. Through this web page, researchers can check …
Curr cancer drug targets impact factor
Did you know?
WebCurrent Cancer Drug Targets is an impact factor journal that covers the full spectrum of cancer drug discovery and development for researchers and oncologists. newsletter banner. ... Researchers can access related articles from current and back volumes by purchasing access to these collections. Subscribers will also have access to new articles ... WebAbout Current Drug Targets. Current Drug Targets aims to cover the latest and most outstanding developments on the medicinal chemistry and pharmacology of molecular …
WebCurrent Cancer Drug Targets. ISSN (Print): 1568-0096 ISSN (Online): 1873-5576. Volume 23 , Issues 11, 2024. This journal supports open access. Back Journal Home Submit Abstracts Submit Manuscripts. Impact Factor. Current: 2.907 5 - Year: 3.516. Ranking & Category. ONCOLOGY 140th of 222; Topic(s) Covered. WebCurrent Cancer Drug Targets is a peer-reviewed medical journal published by Bentham Science Publishers. The editor-in-chief is Ruiwen Zhang ( UH Drug Discovery Institute). …
WebMay 27, 2024 · The impact score (IS) 2024 of Current Cancer Drug Targets is 2.76, which is computed in 2024 as per its definition.Current Cancer Drug Targets IS is decreased … WebHeat shock factor 1 (HSF1) was discovered in 1984 as the master regulator of the heat shock response. ... Curr Cancer Drug Targets. 2024;19(7):515-524. doi: …
WebCurrent Drug Targets SJR Impact Factor 2-year, 3-year, 4-year 2-year Impact Factor. 2.843 3-year Impact Factor. 3.376 4-year Impact Factor 2.843 Scope/Description: Current Drug Targets aims to cover the latest and most outstanding developments on the medicinal chemistry and pharmacology of molecular drug targets e.g. disease specific proteins ...
WebCurrent Cancer Drug Targets is a journal indexed in SJR in Drug Discovery and Pharmacology with an H index of 96. It has an SJR impact factor of 0.732 and it has a best quartile of Q2. It is published in English. It has an SJR … freyja nyitvatartásWebScope Current Cancer Drug Targets aims to cover all the latest and outstanding developments in full spectrum of cancer drug discovery and development, including but … freyholtzWebA systematic review and meta-analysis on overall survival, failure-free survival and safety outcomes in patients with metastatic hormone-sensitive prostate cancer treated with new anti-androgens. Ramos-Esquivel, Allan; Garita-Rojas, Esteban; Masis-Marroquín, Adriana. Anti-Cancer Drugs. 34 (3):405-412, March 2024. Abstract. freyja croissant szövetség utcaWebImpact Factor: 4.850 5-Year Impact Factor: 3.111 Subscribe ISSN: 2212-392X (Online) ISSN: 1574-8936 (Print) Download PDF Flyer. Abstracted & Indexed in: ... Current Cancer Drug Targets. Impact Factor: 2.907 5-Year Impact Factor: 3.516 Subscribe ISSN: 1873-5576 (Online) ISSN: 1568-0096 (Print) freyja buda nyitvatartásWebThe graph shows the changes in the impact factor of Current Cancer Drug Targets and its the corresponding percentile for the sake of comparison with the entire literature. … freyja szövetség utcaWebCurrent Cancer Drug Targets is an impact factor journal that covers the full spectrum of cancer drug discovery and development for researchers and oncologists. ... Current … freyja huld hrólfsdóttirWeb13 rows · About Current Cancer Drug Targets. Current Cancer Drug Targets aims to cover all the latest and ... freyja feh